First Read: Dashenlin Pharmaceutical-20260706
大参林大参林(SH:603233) 瑞银·2026-07-06 11:11

abc 2 July 2026 First Read Dashenlin Pharmaceutical Healthcare virtual tour takeaways: recovering SSSG and accelerating expansion Q2 SSSG improved sequentially; confident on >20% profit growth this year Dashenlin (DSL) mgmt. attended our virtual healthcare tour this week (register here). Mgmt. remains confident in delivering 20%+ earnings growth this year, supported by accelerated store expansion in existing markets, continued GPM expansion across both retail and franchise businesses, and efficiency improve ...

大参林-First Read: Dashenlin Pharmaceutical-20260706 - Reportify